PSY27 THE LONG-TERM COST OF ORTHOPAEDIC SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN HAEMOPHILIA INHIBITOR PATIENTS
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73737-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)73737-2/fulltext
Section Title :
Section Order :
201
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73737-2&doi=10.1016/S1098-3015(10)73737-2